48 related articles for article (PubMed ID: 9631731)
1. [Comparative study of the antineoplastic cytostatic and natural suppressive activity of bone marrow cells].
Seledtsov VI; Seledtsova GV; Taraban VIa; Seniukov VV; Samarin DM; Poveshchenko OV; Kashchenko EA; Kozlov VA
Biull Eksp Biol Med; 1998 Apr; 125(4):437-9. PubMed ID: 9631731
[No Abstract] [Full Text] [Related]
2. [Production by activated lymphocytes of mediators increasing the antitumor cytostatic activity of bone marrow cells].
Seledtsov VI; Taraban VIa; Seledtsova GV; Seniukov VV; Samarin DM; Kashchenko EA; Kozlov VA
Biull Eksp Biol Med; 1998 Jun; 125(6):660-2. PubMed ID: 9693761
[No Abstract] [Full Text] [Related]
3. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
[TBL] [Abstract][Full Text] [Related]
4. [Suppressor and antineoplastic activity of the bone marrow and spleen cells in aging AKR mice].
Bel'skiĭ IuP; Bel'skaia NV; Danilets MG; Stal'bovskaia ES; Kusmartsev SA
Biull Eksp Biol Med; 1999 Apr; 127(4):452-4. PubMed ID: 10367135
[No Abstract] [Full Text] [Related]
5. [Production of mediators enhancing antineoplastic cytostatic activity of bone marrow cells by activated lymphocytes].
Seledtsov VI; Taraban VIa; Seledtsova GV; Seniukov VV; Samarin DM; Kashchenko EA
Biull Eksp Biol Med; 1999 Jan; 127(1):63-5. PubMed ID: 10190008
[No Abstract] [Full Text] [Related]
6. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously.
Dow SW; Fradkin LG; Liggitt DH; Willson AP; Heath TD; Potter TA
J Immunol; 1999 Aug; 163(3):1552-61. PubMed ID: 10415059
[TBL] [Abstract][Full Text] [Related]
7. [The role of interferon-gamma in the regulation of antiproliferative activity of nonadherent bone marrow cells].
Bel'skiĭ IuP; Danilets MG; Bel'skaia NV; Stal'bovskaia ES; Kusmartsev SA
Biull Eksp Biol Med; 1999 Dec; 128(12):677-80. PubMed ID: 10650472
[No Abstract] [Full Text] [Related]
8. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
[TBL] [Abstract][Full Text] [Related]
9. Decreasing endogenous glucocorticoids alters the ability of bone marrow cells to produce nitric oxide in response to stimulating agents.
White AM; Holda JH
Cell Immunol; 2004; 232(1-2):32-7. PubMed ID: 15922713
[TBL] [Abstract][Full Text] [Related]
10. Cultured murine parenchymal liver cells induce differentiation of bone marrow cells to macrophage-like cells which present antigen to Th1 clones but inhibit their proliferation by nitric oxide and prostaglandins.
Mabuchi A; Kitajima-Shimizu M; Kikuchi K; Nakagawa Y; Takahashi H; Kakiuchi T; Yokomuro K
Cell Immunol; 1999 Aug; 196(1):14-22. PubMed ID: 10486151
[TBL] [Abstract][Full Text] [Related]
11. Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA.
Jung CW; Kwon JH; Seol JG; Park WH; Hyun JM; Kim ES; Kim ST; Lee SJ; Kim BK; Lee YY
Am J Hematol; 2004 Mar; 75(3):121-7. PubMed ID: 14978690
[TBL] [Abstract][Full Text] [Related]
12. Innate resistance to Trypanosoma congolense infections: differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57Bl/6 mice.
Kaushik RS; Uzonna JE; Gordon JR; Tabel H
Exp Parasitol; 1999 Jun; 92(2):131-43. PubMed ID: 10366538
[TBL] [Abstract][Full Text] [Related]
13. Protection of mice against leukemia after vaccination with bone marrow-derived dendritic cells loaded with apoptotic leukemia cells.
Paczesny S; Beranger S; Salzmann JL; Klatzmann D; Colombo BM
Cancer Res; 2001 Mar; 61(6):2386-9. PubMed ID: 11289101
[TBL] [Abstract][Full Text] [Related]
14. Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro.
Johnson BD; Hanke CA; Becker EE; Truitt RL
Cell Immunol; 1998 Nov; 189(2):149-59. PubMed ID: 9790729
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis.
Hertz CJ; Mansfield JM
Cell Immunol; 1999 Feb; 192(1):24-32. PubMed ID: 10066343
[TBL] [Abstract][Full Text] [Related]
16. [Study of anti-myeloma activity of interleukin-2 activated bone marrow in vitro].
Liu W; Chen SL; Liu JW; Li X; Xia CQ; Qi M
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):205-8. PubMed ID: 15949260
[TBL] [Abstract][Full Text] [Related]
17. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
Datta N; Mukherjee S; Das L; Das PK
Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow stromal cells induce apoptosis of lymphoma cells in the presence of IFNgamma and TNF by producing nitric oxide.
Xu G; Zhang Y; Zhang L; Ren G; Shi Y
Biochem Biophys Res Commun; 2008 Oct; 375(4):666-70. PubMed ID: 18755151
[TBL] [Abstract][Full Text] [Related]
19. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma.
Chang CJ; Yen ML; Chen YC; Chien CC; Huang HI; Bai CH; Yen BL
Stem Cells; 2006 Nov; 24(11):2466-77. PubMed ID: 17071860
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
